Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Encouraging phase IIa results for DMX-200 in patients with proteinuria

July 14, 2017

Results from phase I trial of oral CR-845 in hemodialysis patients with CKD

July 13, 2017

Bardoxolone methyl granted U.S. orphan drug status for Alport syndrome

July 10, 2017

ADV-7103 granted E.U. orphan drug designation for distal renal tubulopathy acidosis

July 7, 2017

Human adipose-derived stromal cells effectively treat experimental glomerulonephritis

July 5, 2017

Clarus resubmits NDA for Jatenzo

June 27, 2017

Novel SSAO inhibitor UD-014 ameliorates experimental diabetic nephropathy

June 26, 2017

FDA gives breakthrough therapy designation to CR-845 from Cara Therapeutics

June 26, 2017

FDA grants breakthrough therapy designation for OMS-721 in IgA nephropathy

June 14, 2017

New clinical outcomes trial of Jardiance planned in chronic kidney disease

June 13, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...